Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
Rhea-AI Summary
Avanos Medical (NYSE: AVNS) will webcast a conference call to discuss fourth quarter and full year 2025 financial results on Feb. 24, 2026 at 9:00 a.m. ET. A news release with results will be issued before market open that day.
The call will be hosted by CEO Dave Pacitti and SVP/CFO Scott Galovan. Investors can join by phone, register for instant dial-in, or listen to a simultaneous webcast via the Avanos investors website. A replay will be available about two hours after the call and remain accessible for one week.
Positive
- None.
Negative
- None.
News Market Reaction – AVNS
In the Feb 17 session, AVNS gained 0.07%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Oct 27 | Earnings call scheduling | Neutral | -0.8% | Announced Q3 2025 webcast timing and logistics before detailed results. |
| Jul 24 | Earnings call scheduling | Neutral | -1.9% | Set date and access details for Q2 2025 earnings conference call. |
| Apr 28 | Earnings call scheduling | Neutral | +2.8% | Outlined timing and speakers for Q1 2025 financial results webcast. |
| Feb 19 | Earnings call scheduling | Neutral | +0.5% | Announced Q4 and full year 2024 earnings call date and access details. |
| Oct 23 | Earnings call scheduling | Neutral | -0.6% | Provided webcast and dial‑in information for Q3 2024 results discussion. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Similar conference-call scheduling releases have produced minimal stock moves, with an average same‑tag reaction of 0.02%, suggesting these notices are typically low‑impact catalysts.
Over the past five quarters, Avanos has consistently pre‑announced webcast details for its quarterly and year‑end earnings calls, usually about a week in advance. These ‘conferences,earnings’ notices, including Q1–Q4 2024 and Q1–Q3 2025, outlined timing, leadership participants, and replay logistics. Market reactions to these scheduling announcements have stayed close to flat, with moves between roughly -1.9% and +2.83%. Today’s fourth quarter and full year 2025 webcast notice follows this established communications pattern.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The conference call will be hosted by Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer.
To instantly join the conference call by phone, use the following link to register close to the call start time: https://emportal.ink/46QTVgQ
After registering, the system will call you and automatically connect you to the conference call. Alternatively, you may join the call by dialing 1-646-357-8785 or 1-800-836-8184 and you will be connected to the call by an operator.
A simultaneous webcast of the call and the related presentation will be accessible via the Investors section of the Avanos Medical website, https://avanos.investorroom.com/. The replay will be accessible within two hours of the end of the call and will be available for one week. Alternatively, you may dial 1-646-517-4150 or 1-888-660-6345 and enter passcode 71930#.
About Avanos Medical, Inc.
Avanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-webcast-conference-call-discussing-fourth-quarter-and-full-year-2025-financial-results-302688973.html
SOURCE Avanos Medical